These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27276)

  • 1. Differential actions of typical and atypical neuroleptic agents on two behavioural effects of apomorphine in the mouse [proceedings].
    Costall B; Naylor RJ; Nohria V
    Br J Pharmacol; 1978 Jun; 63(2):381P-382P. PubMed ID: 27276
    [No Abstract]   [Full Text] [Related]  

  • 2. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings].
    Ridley RM; Crow TJ
    Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of the mouse circling model to demonstrate enhanced striatal actions for oxiperomide and tiapride following denervation [proceedings].
    Costall B; Naylor RJ; Nohria V
    Br J Pharmacol; 1979 May; 66(1):121P. PubMed ID: 36952
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of neuroleptics--zotepine.
    Puech AJ; Martin P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):1-3. PubMed ID: 2883676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat.
    Cowan A; Dettmar PW; Walter DS
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of new antipsychotic agents: use of animal models.
    Puech AJ; Rioux P; Poncelet M; Brochet D; Chermat R; Simon P
    Neuropharmacology; 1981 Dec; 20(12B):1279-84. PubMed ID: 6119637
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MJ 9022: correlation between neuroleptic potential and stereotypy.
    Sathananthan GL; Sanghvi I; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
    [No Abstract]   [Full Text] [Related]  

  • 10. Adaptational phenomena in neuroleptic treatment.
    Nielsen IM; Christensen AV; Hyttel J
    Adv Biochem Psychopharmacol; 1978; 19():267-74. PubMed ID: 29449
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of gamma-aminobutyric acid in acute and chronic neuroleptic action.
    Scheel-Krüger J; Christensen AV
    Adv Biochem Psychopharmacol; 1980; 24():233-43. PubMed ID: 6105778
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Adv Biochem Psychopharmacol; 1980; 24():341-9. PubMed ID: 6105784
    [No Abstract]   [Full Text] [Related]  

  • 14. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 16. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
    Georgiev VP; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organic selenium compound attenuates apomorphine-induced stereotypy in mice.
    Machado MS; Rosa RM; Dantas AS; Reolon GK; Appelt HR; Braga AL; Henriques JA; Roesler R
    Neurosci Lett; 2006 Dec; 410(3):198-202. PubMed ID: 17052842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.